Zhang et al. [1] showed that ANRIL is not only associated with susceptibility to atherosclerosis and hemorrhagic stroke in stroke populations, but also independently predicts the risk of stroke recurrence and cardiovascular death. This evidence concerns the gene CDKN2B-AS1 and stroke disorder.